PT-141 serves as a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors throughout the body, leading to enhanced sexual response. Preclinical studies have revealed that PT-141 could effectively treat a spectrum of sexual dysfunctions